Current understanding of mycobacterium abscessus infection

Journal of Bacteriology and Virology

Volumn 42, Issue 1, 2012, Pages 17-28

  Choi, Go Eun ^a   Jo, Youngsuk ^a   Shin, Sung Jae ^b  

^a Chungnam National University   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

Infection; Mycobacterium abscessus; Mycobacterium bolletii; Mycobacterium massiliense; Pathophysiology

Indexed keywords

EID: 84997740024     PISSN: 15982467     EISSN: None     Source Type: Journal    
DOI: 10.4167/jbv.2012.42.1.17     Document Type: Review

References (98)

1. Freudenberger RS, Simafranca SM. Cutaneous infection with rapidly-growing mycobacterial infection following heart transplant: a case report and review of the literature. Transplant Proc 2006;38:1526-9.
2. De Groote MA, Huitt G. Infections due to rapidly growing mycobacteria. Clin Infect Dis 2006;42:1756-63.
3. Kim BJ, Im SI, Kim YW, Bai GH, Kim SJ, Lee KH, et al. Identification of Fastidious Mycobacteria other than M. tuberculosis (MOTT) by Comparative Sequence Analysis of rpoB and 16S rDNA. J Bacteriol Virol 2002;32:39-45.
4. Marras TK, Daley CL. Epidemiology of human pulmonary infection with nontuberculous mycobacteria. Clin Chest Med 2002;23:553-67.
5. Daley CL, Griffith DE. Pulmonary disease caused by rapidly growing mycobacteria. Clin Chest Med 2002;23:623-32, vii.
6. Koh WJ, Kwon OJ, Jeon K, Kim TS, Lee KS, Park YK, et al. Clinical significance of nontuberculous mycobacteria isolated from respiratory specimens in Korea. Chest 2006;129:341-8.
7. Koh WJ, Kwon OJ, Lee NY, Kook YH, Lee HK, Kim BJ. First case of disseminated Mycobacterium bolletii infection in a young adult patient. J Clin Microbiol 2009;47:3362-6.
8. Kim HY, Yun YJ, Park CG, Lee DH, Cho YK, Park BJ, et al. Outbreak of Mycobacterium massiliense infection associated with intramuscular injections. J Clin Microbiol 2007;45:3127-30.
9. Jarand J, Levin A, Zhang L, Huitt G, Mitchell JD, Daley CL. Clinical and microbiologic outcomes in patients receiving treatment for Mycobacterium abscessus pulmonary disease. Clin Infect Dis 2011;52:565-71.
10. Huang YC, Liu MF, Shen GH, Lin CF, Kao CC, Liu PY, et al. Clinical outcome of Mycobacterium abscessus infection and antimicrobial susceptibility testing. J Microbiol Immunol Infect 2010;43:401-6.
11. Davis KK, Kao PN, Jacobs SS, Ruoss SJ. Aerosolized amikacin for treatment of pulmonary Mycobacterium avium infections: an observational case series. BMC Pulm Med 2007;7:2.
12. Jönsson BE, Gilljam M, Lindblad A, Ridell M, Wold AE, Welinder-Olsson C. Molecular epidemiology of Myco-bacterium abscessus, with focus on cystic fibrosis. J Clin Microbiol 2007;45:1497-504.
13. Levy I, Grisaru-Soen G, Lerner-Geva L, Kerem E, Blau H, Bentur L, et al. Multicenter cross-sectional study of non-tuberculous mycobacterial infections among cystic fibrosis patients, Israel. Emerg Infect Dis 2008;14:378-84.
14. Aberg JA, Yajko DM, Jacobson MA. Eradication of AIDS-related disseminated Mycobacterium avium complex infection after 12 months of antimycobacterial therapy combined with highly active antiretroviral therapy. J Infect Dis 1998;178: 1446-9.
15. Griffith DE, Girard WM, Wallace RJ Jr. Clinical features of pulmonary disease caused by rapidly growing mycobacteria. An analysis of 154 patients. Am Rev Respir Dis 1993;147: 1271-8.
16. Falkinham JO, Iseman MD, de Haas P, van Soolingen D. Mycobacterium avium in a shower linked to pulmonary disease. J Water Health 2008;6:209-13.
17. Kuo YM, Cheng A, Wu PC, Hsieh SC, Hsieh SM, Hsueh PR, et al. Disseminated Mycobacterium abscessus infection and showerheads, Taiwan. Emerg Infect Dis 2011;17:2077-8.
18. Matsumoto CK, Chimara E, Bombarda S, Duarte RS, Leão SC. Diversity of pulsed-field gel electrophoresis patterns of Mycobacterium abscessus type 2 clinical isolates. J Clin Microbiol 2011;49:62-8.
19. van Ingen J, de Zwaan R, Dekhuijzen RP, Boeree MJ, van Soolingen D. Clinical relevance of Mycobacterium chelonae-abscessus group isolation in 95 patients. J Infect 2009;59:324-31.
20. Duarte RS, Lourenco MC, de Fonseca LS, Leão SC, de Amorim EL, Rocha IL, et al. Epidemic of postsurgical infections caused by Mycobacterium massiliense. J Clin Microbiol 2009; 47:2149-55.
21. Viana-Niero C, Lima K V, Lopes ML, Rabello MC, Marsola LR, Brilhante VC, et al. Molecular characterization of Mycobacterium massiliense and Mycobacterium bolletii in isolates collected from outbreaks of infections after lap-aroscopic surgeries and cosmetic procedures. J Clin Microbiol 2008;46:850-5.
22. Petrini B. Mycobacterium abscessus: an emerging rapid-growing potential pathogen. APMIS 2006;114:319-328.
23. Verweij PE, Figueroa J, Van Burik J, Holdom MD, Dei-Cas E, Gómez BL, et al. Clinical applications of non-culture based methods for the diagnosis and management of opportunistic and endemic mycoses. Med Mycol 2000;38:161-71.
24. Street ML, Umbert-Millet IJ, Roberts GD, Su WP. Non-tuberculous mycobacterial infections of the skin. Report of fourteen cases and review of the literature. J Am Acad Dermatol 1991;24:208-15.
25. Leão SC, Viana-Niero C, Matsumoto CK, Lima KV, Lopes ML, Palaci M, et al. Epidemic of surgical-site infections by a single clone of rapidly growing mycobacteria in Brazil. Future Microbiol 2010;5:971-80.
26. Safranek TJ, Jarvis WR, Carson LA, Cusick LB, Bland LA, Swenson JM, et al. Mycobacterium chelonae wound infections after plastic surgery employing contaminated gentian violet skin-marking solution. N Engl J Med 1987;317:197-201.
27. Devallois A, Picardeau M, Paramasivan CN, Vincent V, Rastogi N. Molecular characterization of Mycobacterium avium complex isolates giving discordant results in AccuProbe tests by PCR-restriction enzyme analysis, 16S rRNA gene sequencing, and DT1-DT6 PCR. J Clin Microbiol 1997;35: 2767-72.
28. Wallace RJ Jr, Meier A, Brown BA, Zhang Y, Sander P, Onyi GO, et al. Genetic basis for clarithromycin resistance among isolates of Mycobacterium chelonae and Mycobacterium abscessus. Antimicrob Agents Chemother 1996;40:1676-81.
29. Koh WJ, Kwon OJ, Suh GY, Chung MP, Kim H, Lee NY, et al. Six-month therapy with aerosolized interferon-gamma for refractory multidrug-resistant pulmonary tuberculosis. J Korean Med Sci 2004;19:167-71.
30. Olivier KN, Weber DJ, Wallace RJ Jr, Faiz AR, Lee JH, Zhang Y, et al. Nontuberculous mycobacteria. I: multicenter prevalence study in cystic fibrosis. Am J Respir Crit Care Med 2003;167:828-34.
31. Roux AL, Catherinot E, Ripoll F, Soismier N, Macheras E, Ravilly S, et al. Multicenter study of prevalence of non-tuberculous mycobacteria in patients with cystic fibrosis in france. J Clin Microbiol 2009;47:4124-8.
32. Chan ED, Bai X, Kartalija M, Orme IM, Ordway DJ. Host immune response to rapidly growing mycobacteria, an emerging cause of chronic lung disease. Am J Respir Cell Mol Biol 2010;43:387-93.
33. Rottman M, Catherinot E, Hochedez P, Emile JF, Casanova JL, Gaillard JL, et al. Importance of T cells, gamma interferon, and tumor necrosis factor in immune control of the rapid grower Mycobacterium abscessus in C57BL/6 mice. Infect Immun 2007;75:5898-907.
34. Byrd TF, Lyons CR. Preliminary characterization of a Myco-bacterium abscessus mutant in human and murine models of infection. Infect Immun 1999;67:4700-7.
35. Brown-Elliott BA, Wallace RJ Jr. Clinical and taxonomic status of pathogenic nonpigmented or late-pigmenting rapidly growing mycobacteria. Clin Microbiol Rev 2002;15:716-46.
36. Catherinot E, Clarissou J, Etienne G, Ripoll F, Emile JF, Daffé M, et al. Hypervirulence of a rough variant of the Myco-bacterium abscessus type strain. Infect Immun 2007;75:1055-1058.
37. Davidson LB, Nessar R, Kempaiah P, Perkins DJ, Byrd TF. Mycobacterium abscessus Glycopeptidolipid Prevents Respiratory Epithelial TLR2 Signaling as Measured by HbetaD2 Gene Expression and IL-8 Release. PLoS One 2011;6:e29148.
38. Ripoll F, Pasek S, Schenowitz C, Dossat C, Barbe V, Rottman M, et al. Non mycobacterial virulence genes in the genome of the emerging pathogen Mycobacterium abscessus. PLoS One 2009;4:e5660.
39. Lee KS, Sohn H, Lee SS, Lee BS, Kim HJ, Shin SJ. Cytokine Profiles of Macrophages by Mycobacterium abscessus Conditional Morphotype Variants and Comparison of Their Extracellular-Protein Expressions. J Bacteriol Virol 2008;38: 109-18.
40. Shin DM, Yang CS, Yuk JM, Lee JY, Kim KH, Shin SJ, et al. Mycobacterium abscessus activates the macrophage innate immune response via a physical and functional interaction between TLR2 and dectin-1. Cell Microbiol 2008;10:1608-21.
41. Ordway D, Henao-Tamayo M, Smith E, Shanley C, Harton M, Troudt J, et al. Animal model of Mycobacterium abscessus lung infection. J Leukoc Biol 2008;83:1502-11.
42. Jeon BY, Kwak J, Lee SS, Cho S, Won CJ, Kim JM, et al. Comparative analysis of immune responses to Mycobacterium abscessus infection and its antigens in two murine models. J Microbiol 2009;47:633-40.
43. Wang H, Jin P, Wu Q. Disseminated cutaneous infection with Mycobacterium abscessus in a patient with a low CD4+ T cell count. Eur J Dermatol 2008;18:337-40.
44. Takewaki S, Okuzumi K, Manabe I, Tanimura M, Miyamura K, Nakahara K, et al. Nucleotide sequence comparison of the mycobacterial dnaJ gene and PCR-restriction fragment length polymorphism analysis for identification of mycobacterial species. Int J Syst Bacteriol 1994;44:159-66.
45. Moore M, Frerichs JB. An unusual acid-fast infection of the knee with subcutaneous, abscess-like lesions of the gluteal region; report of a case with a study of the organism, Mycobacterium abscessus, n. sp. J Invest Dermatol 1953;20: 133-69.
46. Dorff GJ, Frerichs L, Zabransky RJ, Jacobs P, Spankus JD. Musculoskeletal infections due to Mycobacterium kansasii. Clin Orthop Relat Res 1978;136:244-6.
47. Kusunoki S, Ezaki T. Proposal of Mycobacterium peregrinum sp. nov., nom. rev., and elevation of Mycobacterium chelonae subsp. abscessus (Kubica et al.) to species status: Myco-bacterium abscessus comb. nov. Int J Syst Bacteriol 1992; 42:240-5.
48. Adékambi T, Drancourt M. Dissection of phylogenetic relationships among 19 rapidly growing Mycobacterium species by 16S rRNA, hsp65, sodA, recA and rpoB gene sequencing. Int J Syst Evol Microbiol 2004;54:2095-105.
49. Adékambi T, Berger P, Raoult D, Drancourt M. rpoB gene sequence-based characterization of emerging non-tuberculous mycobacteria with descriptions of Mycobacterium bolletii sp. nov., Mycobacterium phocaicum sp. nov. and Mycobacterium aubagnense sp. nov. Int J Syst Evol Microbiol 2006;56:133-43.
50. Leao SC, Tortoli E, Viana-Niero C, Ueki S Y, Lima K V, Lopes ML, et al. Characterization of mycobacteria from a major Brazilian outbreak suggests that revision of the taxonomic status of members of the Mycobacterium chelonae-M. abscessus group is needed. J Clin Microbiol 2009;47:2691-8.
51. Macheras E, Roux AL, Ripoll F, Sivadon-Tardy V, Gutierrez C, Gaillard JL, et al. Inaccuracy of single-target sequencing for discriminating species of the Mycobacterium abscessus group. J Clin Microbiol 2009;47:2596-600.
52. Kim H Y, Kook Y, Yun YJ, Park CG, Lee NY, Shim TS, et al. Proportions of Mycobacterium massiliense and Mycobacterium bolletii strains among Korean Mycobacterium chelonae-Mycobacterium abscessus group isolates. J Clin Microbiol 2008;46:3384-90.
53. Petrini B. Mycobacterium marinum: ubiquitous agent of waterborne granulomatous skin infections. Eur J Clin Microbiol Infect Dis 2006;25:609-613.
54. Martin-Casabona N, Bahrmand AR, Bennedsen J, Thomsen VO, Curcio M, Fauville-Dufaux M, et al. Non-tuberculous mycobacteria: patterns of isolation. A multi-country retrospective survey. Int J Tuberc Lung Dis 2004;8:1186-93.
55. Silcox VA, Good RC, Floyd MM. Identification of clinically significant Mycobacterium fortuitum complex isolates. J Clin Microbiol 1981;14:686-91.
56. Howard ST, Rhoades E, Recht J, Pang X, Alsup A, Kolter R, et al. Spontaneous reversion of Mycobacterium abscessus from a smooth to a rough morphotype is associated with reduced expression of glycopeptidolipid and reacquisition of an invasive phenotype. Microbiology 2006;152:1581-90.
57. Greendyke R, Byrd TF. Differential antibiotic susceptibility of Mycobacterium abscessus variants in biofilms and macro-phages compared to that of planktonic bacteria. Antimicrob Agents Chemother 2008;52:2019-26.
58. Simmon KE, Pounder JI, Greene JN, Walsh F, Anderson CM, Cohen S, et al. Identification of an emerging pathogen, Mycobacterium massiliense, by rpoB sequencing of clinical isolates collected in the United States. J Clin Microbiol 2007; 45:1978-80.
59. Lee H, Park HJ, Cho SN, Bai GH, Kim SJ. Species identification of mycobacteria by PCR-restriction fragment length polymorphism of the rpoB gene. J Clin Microbiol 2000;38: 2966-71.
60. Adékambi T, Colson P, Drancourt M. rpoB-based identification of nonpigmented and late-pigmenting rapidly growing myco-bacteria. J Clin Microbiol 2003;41:5699-708.
61. Whang J, Lee BS, Choi GE, Cho SN, Kil PY, Collins MT, et al. Polymerase chain reaction-restriction fragment length polymorphism of the rpoB gene for identification of Myco-bacterium avium subsp. paratuberculosis and differentiation of Mycobacterium avium subspecies. Diagn Microbiol Infect Dis 2011;70:65-71.
62. Seok SH, Koo HC, Kasuga A, Kim Y, Lee EG, Lee H, et al. Use of PCR-restriction fragment length polymorphism for the identification of zoonotic mycobacteriosis in zebrafish caused by Mycobacterium abscessus and Mycobacterium chelonae. Vet Microbiol 2006;114:292-7.
63. Choi GE, Chang CL, Whang J, Kim HJ, Kwon OJ, Koh WJ, et al. Efficient differentiation of Mycobacterium abscessus complex isolates to the species level by a novel PCR-based variable-number tandem-repeat assay. J Clin Microbiol 2011; 49:1107-9.
64. Sassetti CM, Boyd DH, Rubin EJ. Genes required for mycobacterial growth defined by high density mutagenesis. Mol Microbiol 2003;48:77-84.
65. Brown-Elliott BA, Griffith DE, Wallace RJ Jr. Newly described or emerging human species of nontuberculous mycobacteria. Infect Dis Clin North Am 2002;16:187-220.
66. Garcia-Vallvé S, Palau J, Romeu A. Horizontal gene transfer in glycosyl hydrolases inferred from codon usage in Escherichia coli and Bacillus subtilis. Mol Biol Evol 1999; 16:1125-34.
67. Shin AR, Sohn H, Won CJ, Lee B, Kim WS, Kang HB, et al. Characterization and identification of distinct Mycobacterium massiliense extracellular proteins from those of Mycobacterium abscessus. J Microbiol 2010;48:502-11.
68. No authors listed. Diagnosis and treatment of disease caused by nontuberculous mycobacteria. This official statement of the American Thoracic Society was approved by the Board of Directors, March 1997. Medical Section of the American Lung Association. Am J Respir Crit Care Med 1997;156:S1-25.
69. Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 2007;175:367-416.
70. Zelazny AM, Root JM, Shea YR, Colombo RE, Shamputa IC, Stock F, et al. Cohort study of molecular identification and typing of Mycobacterium abscessus, Mycobacterium massiliense, and Mycobacterium bolletii. J Clin Microbiol 2009;47:1985-1995.
71. Colombo RE, Olivier KN. Diagnosis and treatment of infections caused by rapidly growing mycobacteria. Semin Respir Crit Care Med 2008;29:577-88.
72. Jeon K, Kwon OJ, Lee NY, Kim BJ, Kook YH, Lee SH, et al. Antibiotic treatment of Mycobacterium abscessus lung disease: a retrospective analysis of 65 patients. Am J Respir Crit Care Med 2009;180:896-902.
73. Koh WJ, Jeon K, Lee NY, Kim BJ, Kook YH, Lee SH, et al. Clinical significance of differentiation of Mycobacterium massiliense from Mycobacterium abscessus. Am J Respir Crit Care Med 2011;183:405-10.
74. Lyu J, Jang HJ, Song JW, Choi CM, Oh YM, Lee SD, et al. Outcomes in patients with Mycobacterium abscessus pulmonary disease treated with long-term injectable drugs. Respir Med 2011;105:781-7.
75. Adékambi T, Drancourt M. Mycobacterium bolletii respiratory infections. Emerg Infect Dis 2009;15:302-5.
76. Choi GE, Chang CL, Whang J, Kim HJ, Kwon OJ, Koh WJ, et al. Efficient differentiation of Mycobacterium abscessus complex isolates to the species level by a novel PCR-based variable-number tandem-repeat assay. J Clin Microbiol 2011; 49:1107-9.
77. Blauwendraat C, Dixon GL, Hartley JC, Foweraker J, Harris KA. The use of a two-gene sequencing approach to accurately distinguish between the species within the Mycobacterium abscessus complex and Mycobacterium chelonae. Eur J Clin Microbiol Infect Dis 2012.
78. Kim EK, Shim TS, Lim CM, Lee SD, Koh Y, Kim WS, et al. Clinical manifestations of pulmonary infection due to rapidly growing nontuberculous mycobacteria. Tuberc Respir Dis 2003;54:283-94.
79. Chopra S, Matsuyama K, Hutson C, Madrid P. Identification of antimicrobial activity among FDA-approved drugs for combating Mycobacterium abscessus and Mycobacterium chelonae. J Antimicrob Chemother 2011;66:1533-6.
80. Shen GH, Wu BD, Hu ST, Lin CF, Wu KM, Chen JH. High efficacy of clofazimine and its synergistic effect with amikacin against rapidly growing mycobacteria. Int J Antimicrob Agents 2010;35:400-4.
81. Wallace RJ Jr, Brown-Elliott BA, Ward SC, Crist CJ, Mann LB, Wilson RW. Activities of linezolid against rapidly growing mycobacteria. Antimicrob Agents Chemother 2001;45:764-7.
82. Macheras E, Roux AL, Bastian S, Leão SC, Palaci M, Sivadon-Tardy V, et al. Multilocus sequence analysis and rpoB sequencing of Mycobacterium abscessus (sensu lato) strains. J Clin Microbiol 2011;49:491-9.
83. Lyu J, Jang HJ, Song JW, Choi CM, Oh YM, Lee SD, et al. Outcomes in patients with Mycobacterium abscessus pulmonary disease treated with long-term injectable drugs. Respir Med 2011;105:781-7.
84. Nash KA, Brown-Elliott BA, Wallace RJ Jr. A novel gene, erm(41), confers inducible macrolide resistance to clinical isolates of Mycobacterium abscessus but is absent from Mycobacterium chelonae. Antimicrob Agents Chemother 2009; 53:1367-76.
85. Kim HY, Kim BJ, Kook Y, Yun YJ, Shin JH, Kim BJ, et al. Mycobacterium massiliense is differentiated from Myco-bacterium abscessus and Mycobacterium bolletii by erythro-mycin ribosome methyltransferase gene (erm) and clarithro-mycin susceptibility patterns. Microbiol Immunol 2010;54: 347-53.
86. Saito H, Tomioka H, Sato K, Dekio S. In vitro and in vivo antimycobacterial activities of a new quinolone, DU-6859a. Antimicrob Agents Chemother 1994;38:2877-82.
87. Ji B, Lounis N, Maslo C, Truffot-Pernot C, Bonnafous P, Grosset J. In vitro and in vivo activities of moxifloxacin and clinafloxacin against Mycobacterium tuberculosis. Antimicrob Agents Chemother 1998;42:2066-9.
88. Renna M, Schaffner C, Brown K, Shang S, Tamayo MH, Hegyi K, et al. Azithromycin blocks autophagy and may predispose cystic fibrosis patients to mycobacterial infection. J Clin Invest 2011;121:3554-63.
89. Gevaudan MJ, Bollet C, de Micco P. Evaluation of the extra-and intracellular activity of clarithromycin against Myco-bacterium chelonae. Pathol Biol (Paris) 1994;42:412-8.
90. Wertman R, Miller M, Groben P, Morrell DS, Culton DA. Mycobacterium bolletii/Mycobacterium massiliense furun-culosis associated with pedicure footbaths: a report of 3 cases. Arch Dermatol 2011;147:454-8.
91. Nakanaga K, Hoshino Y, Era Y, Matsumoto K, Kanazawa Y, Tomita A, et al. Multiple cases of cutaneous Mycobacterium massiliense infection in a hot spa in Japan. J Clin Microbiol 2011;49:613-7.
92. Adékambi T. Mycobacterium mucogenicum group infections: a review. Clin Microbiol Infect 2009;15:911-918.
93. Tortoli E, Gabini R, Galanti I, Mariottini A. Lethal Myco-bacterium massiliense sepsis, Italy. Emerg Infect Dis 2008; 14:984-5.
94. Chernenko SM, Humar A, Hutcheon M, Chow CW, Chaparro C, Keshavjee S, et al. Mycobacterium abscessus infections in lung transplant recipients: the international experience. J Heart Lung Transplant 2006;25:1447-55.
95. Cardoso AM, Martins de Sousa E, Viana-Niero C, Bonfim de Bortoli F, Pereira das Neves ZC, Leão SC, et al. Emergence of nosocomial Mycobacterium massiliense infection in Goias, Brazil. Microbes Infect 2008;10:1552-7.
96. Han X Y, Dé I, Jacobson KL. Rapidly growing mycobacteria: clinical and microbiologic studies of 115 cases. Am J Clin Pathol 2007;128:612-21.
97. Esteban J, Fernández Roblas R, García Cía JI, Zamora N, Ortiz A. Clinical significance and epidemiology of non-pigmented rapidly growing mycobacteria in a university hospital. J Infect 2007;54:135-45.
98. Furuya E Y, Paez A, Srinivasan A, Cooksey R, Augenbraun M, Baron M, et al. Outbreak of Mycobacterium abscessus wound infections among lipotourists from the United States who underwent abdominoplasty in the Dominican Republic. Clin Infect Dis 2008;46:1181-8.